


P1NP is a marker of osteoblastic activity and is increased in conditions like Paget’s disease, Osteoporosis, Primary / Secondary Hyperparathyroidism & Osteomalacia. This test is used to monitor effectiveness of therapy, identify noncompliance amongst patients and predict fracture risk.